PN Holding

PN Holding is the primary holding company for the Polpharma Group, the largest Polish manufacturer of pharmaceuticals and a leader in the Central and Eastern European market. The company produces a wide range of prescription drugs, over-the-counter (OTC) products, and active pharmaceutical ingredients (APIs) across multiple therapeutic areas including cardiology, neurology, and gastroenterology. Through its subsidiary Polpharma Biologics, the group has established a significant presence in the global biosimilars market, developing high-quality biologic medicines for complex diseases. PN Holding oversees a vertically integrated operation with state-of-the-art manufacturing facilities and R&D centers located in Poland and the Netherlands. The company is privately held and continues to expand its international footprint through strategic partnerships and acquisitions in emerging markets.